Axogen (AXGN) Profit After Tax (2010 - 2026)
Axogen's (AXGN) quarterly Profit After Tax came in at -$19.6 million in Q1 2026, down 410.8% year-on-year from $6.3 million in Q1 2025, and down 48.86% quarter-over-quarter from -$13.2 million in Q4 2025.
Axogen (AXGN) Profit After Tax (2010 - 2026) Analysis & Trends
Axogen's Profit After Tax history runs 17 years deep, the most recent figure standing at -$19.6 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 410.8% year-over-year to -$19.6 million in Q1 2026; TTM through Mar 2026 was -$31.5 million, a 339.1% decrease from a year earlier, with the FY2025 full-year figure at -$15.7 million, down 57.6% from the prior year.
- Profit After Tax fell to -$19.6 million in Q1 2026 per AXGN's latest filing, from -$13.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $708000.0 in Q3 2025 and bottomed at -$19.6 million in Q1 2026.
- The 5-year median for Profit After Tax is -$4.3 million (2022), against an average of -$5.6 million.
- Biggest YoY gain for Profit After Tax was 138.11% in 2025; the steepest drop was 3023.56% in 2025.
- Year by year, Profit After Tax stood at -$5.4 million in 2022, then grew by 28.11% to -$3.9 million in 2023, then surged by 111.56% to $450000.0 in 2024, then sank by 3023.56% to -$13.2 million in 2025, then tumbled by 48.86% to -$19.6 million in 2026.
- Per Business Quant, the three latest AXGN Profit After Tax figures stand at -$19.6 million (Q1 2026), -$13.2 million (Q4 2025), and $708000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 170.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn | -19.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.58 Mn |
| Dec 31, 2025 | -13.16 Mn |
| Sep 30, 2025 | 708,000.00 |
| Jun 30, 2025 | 579,000.00 |
| Mar 31, 2025 | -3.83 Mn |
| Dec 31, 2024 | 450,000.00 |
| Sep 30, 2024 | -1.86 Mn |
| Jun 30, 2024 | -1.92 Mn |
| Mar 31, 2024 | -6.64 Mn |
| Dec 31, 2023 | -3.89 Mn |
| Sep 30, 2023 | -4.09 Mn |
| Jun 30, 2023 | -6.66 Mn |
| Mar 31, 2023 | -7.07 Mn |
| Dec 31, 2022 | -5.42 Mn |
| Sep 30, 2022 | -4.32 Mn |
| Jun 30, 2022 | -7.74 Mn |
| Mar 31, 2022 | -11.48 Mn |
| Dec 31, 2021 | -5.29 Mn |
| Sep 30, 2021 | -7.14 Mn |
| Jun 30, 2021 | -7.90 Mn |